Pharmstandard unveils Net Profit of $73 million for 1H 2008
Published: 27 August, 2008, 07:36
Russian drugmaker Pharmstandard has reported an 83% jump in Net Profit for 1H 2008 to $73 million under IFRS.
EBITDA came in at $110 million, up 62%, on Revenues of $259 million, up 40%.
The company highlighted strong sales of major products, plus the addition of 8 new products to their range, as well as a continued focus on effectively managing costs, as key drivers for the results.
27.08.2008, 06:25
BMW finds Russian product top classBMW has stated some of its Russian manufactured models are better than its German made cars. The luxury automaker makes 6 and a half thousand units a year at its plant in Kaliningrad's special economic zone. |
27.08.2008, 11:24
Kamaz sees Net Profit up 90% FY 2007Russian truckmaker Kamaz has reported a 90% jump in its Full Year 2007 Net Profit under IFRS. |
